EcoR1 Capital, 10% Owner: Adaptimmune Therapeutics ADAPY Sell · Filed 25/07/30

Trade details

Type: Insider sale
Amount: $3,732,491.4
Shares · price: 33,931,740 sh · $0.11 a share
Held after: 130,492,680 sh
Stock: Adaptimmune Therapeutics ADAPY
Person: EcoR1 Capital10% Owner
Trade date: 25/07/28
Filed: 25/07/30
Days to filing: 2 days

Sold 20.6% of holdings

Share of holding sold: 20.6%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/28~25/08/27

EcoR1 Capital's recent trades

EcoR1 Capital10% Owner
BuyAtara Biotherapeutics
Buy
Atara Biotherapeutics
ATRA
$4.7M
507,407 sh
$4.7M
Filed 05/11
Traded 05/07
EcoR1 Capital10% Owner
SellFirst Tracks Biotherapeutics
Sell
First Tracks Biotherapeutics
TRAX
$65M
4,705,575 sh
$65M
Filed 04/22
Traded 04/20
EcoR1 CapitalDirector
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$37.4M
2,077,779 sh
$37.4M
Filed 01/12
Traded 01/12
EcoR1 CapitalDirector
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$2.6M
144,443 sh
$2.6M
Filed 01/12
Traded 01/12
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2.7M
27,433,338 sh
$2.7M
Filed 25/07/30
Traded 25/07/30